David Horne
57Patents
6h-index
65Co-inventors
75Inventor score
Filing activity: Oct 6, 1995 → Apr 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8962804B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 33 | Active |
| US5834609A | Bicyclic aminoimidazoles | Chemistry; Metallurgy | 25 | Expired |
| US6103899A | Bicyclic aminoimidazoles | Chemistry; Metallurgy | 17 | Expired |
| US9828342B2 | Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof | Chemistry; Metallurgy | 16 | Active |
| US6218549A | Bicyclic aminoimidazoles | Chemistry; Metallurgy | 8 | Expired |
| US6197954A | Intermediates for the synthesis of debromohymenialdisine and processes thereof | Chemistry; Metallurgy | 7 | Expired |
| US8658774B2 | Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US9669108B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US6211361A | Method for making debromohymenialdisine and analogs thereof | Human Necessities | 6 | Expired |
| US8372983B2 | Ribonucleotide reductase inhibitors and methods of use | Chemistry; Metallurgy | 5 | Active |
| US6528646B2 | Intermediates for the synthesis of debromohymenialdisine and process thereof | Chemistry; Metallurgy | 5 | Expired |
| USRE45020E1 | Ribonucleotide reductase inhibitors and methods of use | General | 4 | Active |
| US7956076B2 | Ribonucleotide reductase inhibitors and methods of use | Chemistry; Metallurgy | 4 | Active |
| US9932310B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 4 | Active |
| US8163783B2 | Ribonucleotide reductase inhibitors and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10173984B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 3 | Active |
| US9527868B2 | ETP derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US9126960B2 | Ribonucleotide reductase inhibitors and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10550070B2 | PCNA inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10562856B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 2 | Active |
| US6841685B2 | Methods for making bis-heterocyclic alkaloids | Chemistry; Metallurgy | 2 | Expired |
| US10913706B2 | PCNA inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9598385B2 | Ribonucleotide reductase inhibitors and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9856273B2 | ETP derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US10822353B2 | Dithio ETP derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.